L. Zemoura

459 total citations
24 papers, 213 citations indexed

About

L. Zemoura is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, L. Zemoura has authored 24 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in L. Zemoura's work include Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Research Studies (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). L. Zemoura is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Research Studies (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). L. Zemoura collaborates with scholars based in France, China and Italy. L. Zemoura's co-authors include Charles Advenier, Élisabeth Dulmet, Vincent de Montpréville, Élisabeth Longchampt, Emmanuel Naline, Hélène Salvator, P. Devillier, Amparo Buenestado, Christophe Faisy and Jean‐Claude Alvarez and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Pharmacology and European Respiratory Journal.

In The Last Decade

L. Zemoura

21 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Zemoura France	8	99	57	49	41	33	24	213
Matilde Marchetta Italy	8	74 0.7×	33 0.6×	36 0.7×	33 0.8×	82 2.5×	9	346
Yu Xue China	10	25 0.3×	30 0.5×	45 0.9×	67 1.6×	52 1.6×	28	246
Meng‐Ting Peng Taiwan	9	39 0.4×	106 1.9×	31 0.6×	26 0.6×	50 1.5×	21	280
Zheng-pei Zeng China	11	43 0.4×	31 0.5×	132 2.7×	71 1.7×	80 2.4×	46	348
Aaron Chidakel United States	7	30 0.3×	19 0.3×	63 1.3×	45 1.1×	57 1.7×	8	291
Jianfeng Peng United States	7	29 0.3×	47 0.8×	43 0.9×	39 1.0×	124 3.8×	9	339
A. Hofman Netherlands	4	30 0.3×	42 0.7×	29 0.6×	58 1.4×	113 3.4×	4	293
Aki Ikoma Japan	9	39 0.4×	31 0.5×	60 1.2×	32 0.8×	68 2.1×	23	308
Jiahui Li China	9	131 1.3×	31 0.5×	17 0.3×	14 0.3×	45 1.4×	27	266

Countries citing papers authored by L. Zemoura

Since Specialization

Citations

This map shows the geographic impact of L. Zemoura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Zemoura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Zemoura more than expected).

Fields of papers citing papers by L. Zemoura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Zemoura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Zemoura. The network helps show where L. Zemoura may publish in the future.

Co-authorship network of co-authors of L. Zemoura

This figure shows the co-authorship network connecting the top 25 collaborators of L. Zemoura. A scholar is included among the top collaborators of L. Zemoura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Zemoura. L. Zemoura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zemoura, L., Catherine Daniel, Samia Melaabi, et al.. (2022). Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report. Lung Cancer. 174. 186–187. 5 indexed citations

Assié, Jean‐Baptiste, I. Monnet, Marie-Ange Massiani, et al.. (2020). Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases. Lung Cancer. 150. 21–25. 39 indexed citations

Monnet, I., Marie-Ange Massiani, Jean‐Baptiste Assié, et al.. (2019). MA03.09 Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers. Journal of Thoracic Oncology. 14(10). S259–S259. 2 indexed citations

Zemoura, L., et al.. (2018). Une lésion intra-utérine atypique : tumeur myofibroblastique inflammatoire (TMI). Annales de Pathologie. 38(2). 143–146. 1 indexed citations

Doubre, H., I. Monnet, Anne-Cécile Métivier, et al.. (2018). Réponse à l’immunothérapie des cancers bronchiques non à petites cellules (CBNPC) présentant des mutations induisant un épissage de l’exon 14 du gène MET : à propos de 4 cas. Revue des Maladies Respiratoires. 35. A116–A117. 1 indexed citations

Zemoura, L., et al.. (2016). Une lésion hybride : sarcome fibromyxoïde de bas grade (SFBG) et fibrosarcome épithélioïde sclérosant (FES). Annales de Pathologie. 36(5). 351–354. 1 indexed citations

Grassin‐Delyle, Stanislas, Emmanuel Naline, Amparo Buenestado, et al.. (2014). Cannabinoids inhibit cholinergic contraction in human airways through prejunctionalCB₁receptors. British Journal of Pharmacology. 171(11). 2767–2777. 37 indexed citations

Vieira, Thibault, Aurélie Cazes, P. Bonnette, et al.. (2012). Is conventional chemotherapy effective in advanced sarcomatoid lung cancers?. Journal of Clinical Oncology. 30(15_suppl). e18102–e18102. 4 indexed citations

Girod, Angélique, Alain Chapelier, A. Carlotti, et al.. (2011). Giant basal cell carcinoma with regional lymph node and distant lung metastasis. European Journal of Dermatology. 21(6). 972–975. 14 indexed citations

10.

Gonin, François & L. Zemoura. (2011). Échoendoscopie bronchique. Revue de Pneumologie Clinique. 67(4). 233–237.

11.

Devillier, Philippe, et al.. (2009). Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux. European Respiratory Journal. 35(6). 1370–1376. 34 indexed citations

12.

Zemoura, L., et al.. (2009). Myocardite aspergillaire. Annales de Pathologie. 29(5). 428–430.

13.

Karras, A., P. De Lentdecker, Michel Delahousse, et al.. (2008). Combined Heart and Kidney Transplantation in a Patient with Fabry Disease in the Enzyme Replacement Therapy Era. American Journal of Transplantation. 8(6). 1345–1348. 16 indexed citations

14.

Picard, C., Dominique Grenet, Christiane Copie‐Bergman, et al.. (2006). Small-cell Lung Carcinoma of Recipient Origin After Bilateral Lung Transplantation For Cystic Fibrosis. The Journal of Heart and Lung Transplantation. 25(8). 981–984. 15 indexed citations

15.

Montpréville, Vincent de, et al.. (2004). Endocardial location of familial myofibromatosis revealed by cerebral embolization: cardiac counterpart of the frequent intravascular growth of the disease?. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 444(3). 300–303. 6 indexed citations

16.

Molitor, JL, Antonio Llombart‐Cussac, Guinebretière Jm, et al.. (1997). [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature].. PubMed. 84(2). 206–11. 11 indexed citations

17.

Gilles, R., et al.. (1995). Fibroadenomas of the breast: histopathological/dynamic contrast-enhanced MR correlation. European Radiology. 5(5). 1 indexed citations

18.

Contesso, G, B Zafrani, A Mazabraud, et al.. (1987). [The role of the pathologist in the treatment of osteogenic sarcoma].. PubMed. 73(4). 301–6. 3 indexed citations

19.

Zemoura, L., et al.. (1984). [Granular myoblastoma of the breast. Apropos of 7 cases].. PubMed. 4(2). 151–6. 3 indexed citations

20.

Devaux, Alain, et al.. (1982). [The ano-rectal transitional zone in man: optical and ultrastructural studies (107 observations) (author's transl)].. PubMed. 6(2). 177–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact